Product Information
OLANZAPINE 10 MG VIAL is a generic product labeled by Eugia US LLC, priced at $20.9230 per EA under NDC 55150030801. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Oct 22, 2020. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/1
Manufacturer
Eugia US LLCNDC
55150030801
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA210968FDA Approved
10/22/2020
TE Code
AP
On Market Since
10/22/2020
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE 10 MG VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.9230 per EA |
|---|---|
| All-time high | $34.6950 (Sep 11, 2024) |
| All-time low | $20.9230 (Sep 23, 2026) |
| 52-week high | $23.8100 |
| 52-week low | $20.9230 |
| Median price | $25.3820 |
| Average price | $26.1182 |
| Largest weekly change | -26.8% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OLANZAPINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OLANZAPINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE 10 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE 10 MG VIAL, manufactured by Eugia US LLC, is $20.9230 per EA (NDC 55150030801), effective Sep 30, 2026.
How has the price of OLANZAPINE 10 MG VIAL changed over time?
Over the history we have for it, the NADAC for OLANZAPINE 10 MG VIAL has declined 39.7%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for OLANZAPINE 10 MG VIAL?
Since Apr 17, 2024, the NADAC for OLANZAPINE 10 MG VIAL has ranged from a low of $20.9230 (Sep 23, 2026) to a high of $34.6950 (Sep 11, 2024), with a median of $25.3820 per EA.
Are there cheaper alternatives to OLANZAPINE 10 MG VIAL?
No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE 10 MG VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE 10 MG VIAL?
OLANZAPINE 10 MG VIAL (NDC 55150030801) is labeled by Eugia US LLC, and CMS classifies it as a generic product.